Danny R. Welch, PhD

Professor of Cancer Biology
University of Kansas Cancer Center
Kansas City, Kansas

Danny R. Welch, PhD, is a cancer biologist whose laboratory has discovered eight of the 30 known metastasis suppressor genes. His laboratory has also recently discovered how some of those metastasis suppressors function and is designing therapies to take advantage of their mechanisms of action. He is author of more than 192 peer-reviewed publications and more than 20 book chapters. He is also co-editor of the textbook Cancer Metastasis.

After receiving a B.S. degree in biology from the University of California-Irvine and a PhD in biomedical sciences at the University of Texas-Houston under the tutelage of Garth Nicolson, Dr. Welch worked in the pharmaceutical industry studying cancer biology and virology before joining Pennsylvania State University College of Medicine in 1990 as one of the original faculty in the Jake Gittlen Cancer Research Institute. While in Hershey, Dr. Welch served in numerous roles, including as a member of the ACS Pennsylvania Division board of directors and director of the National Foundation for Cancer Research Center for Metastasis Research. In 2002, Dr. Welch’s laboratory moved to the University of Alabama - Birmingham where he became the Leonard H. Robinson professor of pathology. He also served as professor of cell biology and pharmacology/toxicology as well as a senior member in the UAB Comprehensive Cancer Center, Center for Metabolic Bone Disease, Gene Therapy Center, Skin Diseases Research Center, Center for Biophysical Sciences and Engineering and the Biomedical Engineering and Regenerative Medicine Center.

In 2011, he founded a new Department of Cancer Biology at the University of Kansas Cancer Center, was named Hall Family Foundation endowed chair in molecular medicine, Kansas Bioscience Authority Eminent Scholar and associate director for basic sciences and education at the NCI-designated University of Kansas Cancer Center. Welch is currently professor of cancer biology but also has appointments as professor of pathology and professor of molecular and integrative physiology. He is currently a Komen scholar and president of the Cancer Biology Training Consortium. He has served on numerous grant review panels for the NIH, DOD, ACS, Komen, European Union as well as other international agencies.

Dr. Welch has served as editor-in-chief for Clinical and Experimental Metastasis and is currently deputy editor at Cancer Research as well as an associate editor for numerous other editorial boards. He is also the recipient of numerous mentoring and teaching awards.